ONCLIVE.COM KEYWORD DENSITY CHECKER

Total words: 6240 | 2-word phrases: 1567 | 3-word phrases: 1850 | 4-word phrases: 2010

PAGE INFO

Title Try to keep the title under 60 characters (56 characters)
OncLive - Clinical Oncology News, Cancer Expert Insights
Description Try to keep the meta description between 50 - 160 characters (141 characters)
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Keywords Meta keywords are not recommended anymore (141 characters)
Clinical Oncology News,cancer news,Cancer Expert Insights
H1 No H1 tag on the page (0 characters)

ONE WORD PHRASES 813 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1in9211.32%
2of8510.46%
3and749.10%
4the668.12%
5cancer607.38%
6md415.04%
7testing384.67%
82024364.43%
9a334.06%
10with323.94%

TWO WORD PHRASES 1567 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1biomarker testing201.28%
2biomarker testing?201.28%
3patients with181.15%
4what is150.96%
5in the140.89%
6lung cancer120.77%
7breast cancer110.70%
8is a100.64%
9md phd90.57%
10what are90.57%
11in nsclc?90.57%
1221st 202490.57%
13may 20th90.57%
1420th 202490.57%
15testing in90.57%
16in nsclc90.57%
17cancer car80.51%
18cancer by80.51%
19ngs testing?70.45%
20view more70.45%

THREE WORD PHRASES 1850 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1what is a80.43%
2may 20th 202480.43%
3may 21st 202460.32%
4what are the60.32%
5in lung cancer60.32%
6how do you60.32%
7adjuvant therapy in50.27%
8benefits and side50.27%
9of an ngs50.27%
10an ngs testing50.27%
11ngs testing report50.27%
12image credit ©50.27%
13may 22nd 202450.27%
14in biomarker testing?50.27%
15do you explain50.27%
16advanced or metastatic40.22%
17md phd of40.22%
18the benefits and40.22%
19and side effects40.22%
20side effects of40.22%
21by ryan scottmay40.22%
22by megan hollaschmay40.22%
23biomarker testing in40.22%
24the use of40.22%
25lung cancer dr40.22%
26danafarber cancer institute40.22%
27are the benefits40.22%
28subcutaneous nivolumab in40.22%
29or metastatic solid40.22%
30by kyle doherty40.22%

FOUR WORD PHRASES 2010 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1an ngs testing report50.25%
2how do you explain50.25%
3adjuvant therapy in nsclc?40.20%
4are the benefits and40.20%
5by kyle doherty may40.20%
6what are the benefits40.20%
7of an ngs testing40.20%
8in lung cancer dr40.20%
9advanced or metastatic solid40.20%
10benefits and side effects40.20%
11testing platform in biomarker30.15%
12testing in lung cancer30.15%
13predictive biomarkers for treatment30.15%
14biomarkers for treatment with30.15%
15a certain testing platform30.15%
16certain testing platform in30.15%
17platform in biomarker testing?30.15%
18mutation and a gene30.15%
19for rr tall and30.15%
20gene mutation and a30.15%
212024 the fda has30.15%
22choosing a certain testing30.15%
23results from the mylung30.15%
24egfrmutated nsclc in the30.15%
25among egfrmutated nsclc in30.15%
26tissue and plasmabased mechanisms30.15%
27fda updates pdufa date30.15%
28to firstline osimertinib in30.15%
29nivolumab in advanced or30.15%
30is dna and rna30.15%
31what is dna and30.15%
32subcutaneous nivolumab in advanced30.15%
33in egfrmutant nsclc a30.15%
34osimertinib in egfrmutant nsclc30.15%
35firstline osimertinib in egfrmutant30.15%
36resistance to firstline osimertinib30.15%
37what is a chromosomal30.15%
38for subcutaneous nivolumab in30.15%
39bla for subcutaneous nivolumab30.15%
40diagnostic testing turnaround times30.15%

EXTERNAL LINKS

# URL Whois Check
1https://www.medicalworldnews.com/ Whoismedicalworldnews.com
2 https://www.giantsofcancercare.com/rsvp Whoisgiantsofcancercare.com
3 https://www.gotoper.com/pages/events Whoisgotoper.com
4 https://www.facebook.com/OncLive Whoisfacebook.com
5 https://twitter.com/onclive Whoistwitter.com
6 https://www.linkedin.com/groups/4266350/ Whoislinkedin.com
7 http://www.youtube.com/user/OncLiveTV Whoisyoutube.com
8 https://www.gotoper.com/courses/medical-crossfire-critical-questions-on-diagnosis-sequencing-and-selection-of-systemic-and-radioligand-therapy-options-for-patients-with-gep-nets?utm_source=onclive&utm_medium=homePage&utm_campaign=cmeDeck Whoisgotoper.com
9 https://www.gotoper.com/courses/medical-crossfire-expert-exchanges-to-maximize-clinical-outcomes-for-patients-with-crpc-through-evidence-based-personalized-therapy-ei20?utm_source=onclive&utm_medium=homePage&utm_campaign=cmeDeck Whoisgotoper.com
10 https://www.gotoper.com/courses/community-practice-connections-16th-annual-interdisciplinary-prostate-cancer-congress-and-other-genitourinary-malignancies?utm_source=onclive&utm_medium=homePage&utm_campaign=cmeDeck Whoisgotoper.com
11 https://www.gotoper.com/courses/patient-provider-and-caregiver-connectiontm-addressing-pediatric-and-aya-patient-concerns-while-managing-hodgkin-lymphoma?utm_source=onclive&utm_medium=homePage&utm_campaign=cmeDeck Whoisgotoper.com
12 https://www.gotoper.com/courses/annual-oncology-meeting?utm_source=onclive&utm_medium=homePage&utm_campaign=cmeDeck Whoisgotoper.com
13 https://www.gotoper.com/courses/the-top-10-oncogenic-drivers-in-nsclc-for-2023-what-you-need-to-know-on-tumor-testing-targets-and-treatment-strategies-to-move-the-field-forward-9b6u?utm_source=onclive&utm_medium=homePage&utm_campaign=cmeDeck Whoisgotoper.com
14 https://www.gotoper.com/courses/patient-provider-and-caregiver-connection-individualizing-care-for-patients-with-schizophreniaunderstanding-patient-challenges-and-the-role-of-innovative-treatment?utm_source=onclive&utm_medium=homePage&utm_campaign=cmeDeck Whoisgotoper.com
15 https://www.gotoper.com/courses/expert-illustrations-commentaries-exploring-the-mechanistic-rationale-for-targeting-fgfr2-and-pan-fgfr-in-cca?utm_source=onclive&utm_medium=homePage&utm_campaign=cmeDeck Whoisgotoper.com
16 https://www.cancernetwork.com Whoiscancernetwork.com
17 https://www.cgtlive.com/ Whoiscgtlive.com
18 https://www.curetoday.com Whoiscuretoday.com
19 https://www.oncnursingnews.com/ Whoisoncnursingnews.com
20 https://www.targetedonc.com/ Whoistargetedonc.com
21 https://www.facebook.com/OncLive Whoisfacebook.com
22 https://twitter.com/onclive Whoistwitter.com
23 https://www.linkedin.com/groups/4266350/ Whoislinkedin.com
24 http://www.youtube.com/user/OncLiveTV Whoisyoutube.com